Arcoma

Arcoma P/B

The P/B (Price-to-Book Ratio) of Arcoma (ARCOMA.ST) as of Oct 24, 2026 is 1.46. In the previous year, P/B (Price-to-Book Ratio) was 1.83 — a change of -20.60% (lower).

P/B

1.46

YoY

-20.60%

Last updated:

P/B (Price-to-Book Ratio) of Arcoma is 2025 1.46 . P/B (Price-to-Book Ratio) of Arcoma was 2024 1.83 . It decreases by -20.60% lower compared to the previous year.

The Arcoma P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
2.79 SEK
Jan 1, 2019
2.41 SEK
Jan 1, 2020
2.20 SEK
Jan 1, 2021
2.47 SEK
Jan 1, 2022
2.37 SEK
Jan 1, 2023
2.23 SEK
Jan 1, 2024
1.83 SEK
Jan 1, 2025
1.46 SEK
The Arcoma P/B history
YEARP/BYoY
1.46-20.60%
1.83-17.99%
2.23-5.72%
2.37-4.00%
2.47+12.47%
2.20-8.77%
2.41-13.61%
2.79+4.61%
2.66-8.54%
2.91+33.65%
2.18-16.41%
2.61—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

P/B (Price-to-Book Ratio) of Arcoma is 1.46 in 2025.

P/B (Price-to-Book Ratio) of Arcoma changed from 1.83 to 1.46, representing a -20.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Arcoma since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Arcoma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Arcoma

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Arcoma